BioPharma Credit to raise $300m to fund more investment
BioPharma Credit, a closed end investment fund that provides debt capital for the life sciences industry, is to raise $300m through a primary placement of new shares to fund further investments.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast